Core Viewpoint - Goldman Sachs reported strong earnings driven by growth in investment banking and trading fees, despite some challenges in revenue and expenses [2][3][4]. Financial Performance - For Q4 2025, Goldman Sachs reported earnings per share (EPS) of $14.01, exceeding the estimated $11.70 [2][4]. - The company's actual revenue was $13.45 billion, slightly below the estimated $14.52 billion [3]. - For the full year 2025, net revenues reached $58.28 billion, a 9% increase from 2024, with net earnings of $17.18 billion and an EPS of $51.32, up from $40.54 in 2024 [5]. Revenue Breakdown - Equities trading revenues increased by 25% year over year, totaling $4.31 billion [2][6]. - Fixed income, currency, and commodities trading revenues rose by 12% to $3.11 billion [2][6]. - Investment banking fees saw a 25% increase, amounting to $2.58 billion, driven by heightened deal-making activity [3][6]. - Advisory revenues grew by 41%, attributed to a rise in completed mergers and acquisitions [3]. Challenges - The company faced rising expenses and losses in its Platform Solutions segment, particularly related to Apple Card loans [4][5].

NEW YORK, Jan. 15, 2026 (GLOBE NEWSWIRE) -- Kirby McInerney LLP reminds investors who purchased Ardent Health, Inc. (“Ardent” or the “Company”) (NYSE:ARDT) securities to contact Lauren Molinaro of Kirby McInerney LLP by email at investigations@kmllp.com, or fill out the contact form below, to discuss your rights or interests in the securities fraud class action lawsuit at no cost. If you suffered a loss on your Ardent investments, you have until March 9, 2026 to request lead plaintiff appointment. Follow th ...

VANCOUVER, BC / ACCESS Newswire / January 15, 2026 / LIR Life Sciences Corp. (CSE:SKNY)(OTC PINK:BBCMF)(Frankfurt:N790, WKN:A41QA9) ("LIR" or the "Company")is pleased to announce the launch of a controlled comparative animal study designed to evaluate cell-penetrating peptide (CPP) mediated, needle-free transdermal delivery of second generation GLP/GIP-based obesity therapies. This in vivo study represents an important next step towards advancing LIR's transdermal platform from design-stage planning into fu ...

Question-and-Answer SessionYu ShiNeedham & Company, LLC, Research Division All right. Now let's get started. Shelagh, I would like to address this question off the top of investors' minds immediately. So last year, you guys closed the [indiscernible] acquisition. I think it's an achievement, maybe still a little bit underappreciated given the very tough geopolitical backdrop. But also last year, you guys had to cut outlook around the fiscal Q3 quite meaningfully. And we all knew that there was -- also was a ...

See more: "Energy Transfer Seizes Data Center Growth Opportunities†During a recent webcast, Stacey Morris, head of energy research at VettaFi, said that the long-term demand for natural gas is a bright spot for midstream companies. Current natural gas pipeline projects now span every major U.S. region to support this utility and industrial power demand growth. Highlights include: ETF Exposure to the Natural Gas Companies Capitalizing on AI Energy Demands The Alerian Energy Infrastructure ETF (ENFR) offers ...

Skip to main content Exclusive news, data and analytics for financial market professionalsLearn more aboutRefinitiv AI hyperscalers will drive higher US corporate bond supply in 2026, analysts say January 15, 202610:54 PM UTCUpdated ago By Matt Tracy AI letters and robot hand are placed on computer motherboard in this illustration created on June 23, 2023. REUTERS/Dado Ruvic/Illustration/File Photo Purchase Licensing Rights, opens new tab WASHINGTON, Jan 15 (Reuters) - U.S. corporate bond issuance is expect ...

NEW YORK, Jan. 15, 2026 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers of securities of Varonis Systems, Inc. (NASDAQ: VRNS) common stock between February 4, 2025 and October 28, 2025, both dates inclusive (the "Class Period"). A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than March 9, 2026. So what: If you purchased Varonis securities during the Class ...

After outperforming Nvidia last year, this growth stock still looks attractive.Following a year in which the S&P 500 rose 16% and the Nasdaq Composite jumped 20%, many growth stocks now look overpriced. But if you look close enough, there are a few growth stocks that still look attractive even after last year's big gains. Online broker Interactive Brokers (IBKR +3.20%), which boasts a low-cost and highly automated operation, arguably stands out as one of the few fast-growing companies that still look attrac ...

I think there's a strong case to be made that Microsoft Corporation ( MSFT ) is one of the best and most innovative businesses ever created. I've been lucky enough to participate in its growth overWelcome to Cash Flow Venue, where dividends do the heavy lifting! Blending my financial chops with the timeless wisdom of value investing (and love for steady income), I’ve built a rock-solid pillar in my financial foundation through dividend investing. I believe it’s one of the most accessible paths to achieving ...

Not for distribution to United States newswire services or for dissemination in the United States VANCOUVER, British Columbia, Jan. 15, 2026 (GLOBE NEWSWIRE) -- ATHA Energy Corp. (TSXV:SASK) (FRA:X5U) (OTCQB:SASKF) (“ATHA” or the “Company”) announces today that it has entered into an agreement pursuant to which Canaccord Genuity Corp. and CIBC World Markets have agreed to act as co-lead agents and joint bookrunners, for and on behalf of a syndicate of agents (the “Agents”), in connection with a best efforts ...